Literature DB >> 2155503

Immunological cross-reactivity to laboratory-produced HPV-11 virions of polysera raised against bacterially derived fusion proteins and synthetic peptides of HPV-6b and HPV-16 capsid proteins.

N D Christensen1, J W Kreider, N M Cladel, D A Galloway.   

Abstract

Polysera raised in rabbits to bacterially derived fusion proteins and synthetic peptides of the L1 and L2 ORFs of HPV-6b and -16 were tested for cross-reactivity to laboratory-produced infectious HPV-11 virions. The polysera were analyzed in a series of five different immunological assays including immunoperoxidase staining of the koilocytotic nuclei in sections of formalin-fixed, paraffin-embedded as well as fresh frozen sections of HPV-11 experimental condylomas generated in the athymic nude mouse xenograft system, ELISA, Western blots, and neutralization of infectious HPV-11 virions. ELISA and Western blot assays were used to determine whether the polysera identified external or internal epitopes on HPV-11 virions, and whether there was cross-reactivity to BPV-1 or laboratory-produced CRPV virions. Seven of a total of 12 sera were positive for reactivity to HPV-11 in one or more assays, but none of the reactivity was directed to external epitopes on the intact virions as determined by ELISA. None of the L1 products generated group-specific antigen (GSA) antisera including a synthetic peptide spanning the GSA site. The combination of assays clearly demonstrated that apparent false positive and false negative reactivities of different antisera were obtained for each assay system tested. Thus, no single assay could be used reliably to determine the true antiviral reactivity of a given polysera.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2155503     DOI: 10.1016/0042-6822(90)90180-y

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

1.  Antibody detection in tear samples as a surrogate to monitor host immunity against papillomavirus infections in vaccinated and naturally infected hosts.

Authors:  Jiafen Hu; Sarah Brendle; Karla Balogh; Stephanie Bywaters; Neil Christensen
Journal:  J Gen Virol       Date:  2014-06-05       Impact factor: 3.891

2.  Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11.

Authors:  N D Christensen; J W Kreider; N M Cladel; S D Patrick; P A Welsh
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

3.  Antibody-mediated neutralization in vivo of infectious papillomaviruses.

Authors:  N D Christensen; J W Kreider
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

4.  Antigenic and immunogenic epitopes shared by human papillomavirus type 16 and bovine, canine, and avian papillomaviruses.

Authors:  L Dillner; P Heino; J Moreno-Lopez; J Dillner
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

5.  Interactions between papillomavirus L1 and L2 capsid proteins.

Authors:  Renée L Finnen; Kimberly D Erickson; Xiaojiang S Chen; Robert L Garcea
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

6.  Mother-infant transfer of anti-human papillomavirus (HPV) antibodies following vaccination with the quadrivalent HPV (type 6/11/16/18) virus-like particle vaccine.

Authors:  Katie Matys; Sara Mallary; Oliver Bautista; Scott Vuocolo; Ricardo Manalastas; Punee Pitisuttithum; Alfred Saah
Journal:  Clin Vaccine Immunol       Date:  2012-04-18

7.  Comparisons of VLP-Based ELISA, Neutralization Assays with Native HPV, and Neutralization Assays with PsV in Detecting HPV Antibody Responses in HIV-Infected Women.

Authors:  Ping Du; Sarah Brendle; Janice Milici; Fabian Camacho; John Zurlo; Neil Christensen; Craig Meyers
Journal:  J AIDS Clin Res       Date:  2015-03

8.  Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts.

Authors:  C E Greer; C M Wheeler; M B Ladner; K Beutner; M Y Coyne; H Liang; A Langenberg; T S Yen; R Ralston
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

Review 9.  Pathobiology of papillomavirus-related cervical diseases: prospects for immunodiagnosis.

Authors:  C P Crum; S Barber; J K Roche
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

10.  Differential binding patterns to host cells associated with particles of several human alphapapillomavirus types.

Authors:  Tatevik R Broutian; Sarah A Brendle; Neil D Christensen
Journal:  J Gen Virol       Date:  2009-10-21       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.